Desenvolvimento de procedimento em fluxo com detecção espectrofotométrica para análise de bromoprida em medicamentos e/ou fluido biológico

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Estudo biológico e desenvolvimento de formulação do sal tetrapalmitato de clorexidina para uso em doenças bucais

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Obtenção de nanoanticorpos e síntese de compostos antichagásicos derivados de tiossemicarbazona

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Síntese e citotoxicidade de curcuminoides e híbridos curcumina-cinamaldeído

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Valorizzazione di molecole da materie prime rinnovabili: la trasformazione del 2,5-diidrossimetilfurano con catalisi acida

The present work is part of a larger project aimed at obtaining compounds of industrial interest from renewable sources. The work is particularly aimed to investigate the reactivity of 2,5-bis-hydroxymethylfuran (BHMF), an important building block of organic nature easily obtainable from biomass, with acid catalysis. Through the study of the reactivity of BHMF in water, in the presence of an heterogeneous acid catalyst (Amberlyst 15), has been developed a new synthetic method for the preparation of α-6-hydroxy-6-methyl-4-enyl-2H-pyran-3-one a derivative whose molecular skeleton is similar to that of natural products which are used in pharmaceutical chemistry. The product is obtained in milder conditions and with better selectivity with respect to the strongly oxidizing conditions with which it is prepared in the literature starting from different precursors containing furan ring.

Computational approaches for the design of peptides with anti-breast cancer properties

Background: Breast cancer is the most common cancer among women. Tamoxifen is the preferred drug for estrogen receptor-positive breast cancer treatment, yet many of these cancers are intrinsically resistant to tamoxifen or acquire resistance during treatment. Therefore, scientists are searching for breast cancer drugs that have different molecular targets. Methodology: Recently, a computational approach was used to successfully design peptides that are new lead compounds against breast cancer. We used replica exchange molecular dynamics to predict the structure and dynamics of active peptides, leading to the discovery of smaller bioactive peptides. Conclusions: These analogs inhibit estrogen-dependent cell growth in a mouse uterine growth assay, a test showing reliable correlation with human breast cancer inhibition. We outline the computational methods that were tried and used along with the experimental information that led to the successful completion of this research.

NOVEL AMINO ACID TRANSPORTER-TARGETED RADIOTRACERS FOR BREAST CANCER IMAGING

Breast cancer is the most common malignancy among women in the world. Its 5-year survival rate ranges from 23.4% in patients with stage IV to 98% in stage I disease, highlighting the importance of early detection and diagnosis. 18F-2-Fluoro-2-deoxy-glucose (18F-FDG), using positron emission tomography (PET), is the most common functional imaging tool for breast cancer diagnosis currently. Unfortunately, 18F-FDG-PET has several limitations such as poorly differentiating tumor tissues from inflammatory and normal brain tissues. Therefore, 18F-labeled amino acid-based radiotracers have been reported as an alternative, which is based on the fact that tumor cells uptake and consume more amino acids to sustain their uncontrolled growth. Among those radiotracers, 18F-labeled tyrosine and its derivatives have shown high tumor uptake and great ability to differentiate tumor tissue from inflammatory sites in brain tumors and squamous cell carcinoma. They enter the tumor cells via L-type amino acid transporters (LAT), which were reported to be highly expressed in many cancer cell lines and correlate positively with tumor growth. Nevertheless, the low radiosynthesis yield and demand of an on-site cyclotron limit the use of 18F-labeled tyrosine analogues. In this study, four Technetium-99m (99mTc) labeled tyrosine/ AMT (α-methyl tyrosine)-based radiotracers were successfully synthesized and evaluated for their potentials in breast cancer imaging. In order to radiolabel tyrosine and AMT, the chelators N,N’-ethylene-di-L-cysteine (EC) and 1,4,8,11-tetra-azacyclotetradecane (N4 cyclam) were selected to coordinate 99mTc. These chelators have been reported to provide stable chelation ability with 99mTc. By using the chelator technology, the same target ligand could be labeled with different radioisotopes for various imaging modalities for tumor diagnosis, or for internal radionuclide therapy in future. Based on the in vitro and in vivo evaluation using the rat mammary tumor models, 99mTc-EC-AMT is considered as the most suitable radiotracer for breast cancer imaging overall, however, 99mTc-EC-Tyrosine will be more preferred for differential diagnosis of tumor from inflammation.

AM 6545: A Novel Peripheral CB1 Antagonist

Obesity and other related metabolic disorders are a common problem in the United States. Consequently, several drug therapies have been developed in an attempt to address this problem. Many older appetite suppressants, such as amphetamines, were dangerous and potentially addictive. For the last few years, the endocannabinoid system was investigated as a potential target for appetite suppression. Unfortunately, early cannabinoid CB1 antagonists came with an unacceptable side effect profile of their own, which is largely due to central actions of these drugs. In an attempt to reduce the side effect profile, researchers are investigating peripherally acting cannabinoid antagonists, which do not penetrate the blood brain barrier. This study investigated AM 6545, a novel peripheral cannabinoid antagonist, for its effects on food reinforced instrumental behavior. In the end, the results indicated that AM6545 produced a dose-related suppression of lever pressing for food reinforcement.

Chemia rationalis rationibus philosophicis, observationibus medicis, debitis dosibus, &c illustrata : cum Indice capitum, medicamentorum, eorumque dosium : accesit Praxis chymiatrica rationalis, demonstrans qua in re ... restitui : cum triplici indice ... /

Mode of access: Internet.

Duncani Bornetti Scoti Iatrochymicus, siue De praeparatione et compositione medicamentorum chymicorum artificiosa, tractatus ...

Mode of access: Internet.

Felix Hoppe-Seyler's Handbuch der physiologisch- und pathologisch-chemischen Analyse für Aerzte und Studirende /

Includes bibliographical references and index.

Chimie médicinale : contenant la maniere de préparer les remedes les plus usités, et la méthode de les employer pour la guérison des maladies /

Mode of access: Internet.

Repetitorium der anorganischen chemie mit besonderer rücksicht auf die studiren den der medicin und pharmacie : mit 28 holzstichen.

Mode of access: Internet.

Incompatibilities in prescriptions.

Mode of access: Internet.

Hand book of practical assaying of drugs and galenicals ...

Mode of access: Internet.